At a glance
- Originator Mochida Pharmaceutical
- Class Antiallergics; Benzimidazoles; Small molecules
- Mechanism of Action Helper-inducer T-lymphocyte modulators; Interleukin 4 inhibitors; Interleukin 5 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic asthma
Most Recent Events
- 16 Feb 2006 Discontinued - Preclinical for Allergic asthma in Japan (PO)
- 17 Dec 2003 No development reported - Preclinical for Allergic asthma in Japan (PO)
- 18 Sep 2000 Preclinical development for Allergic asthma in Japan (PO)